NovoCure Limited Increase (Decrease) in Inventories
NovoCure Limited (NVCR) reported Increase (Decrease) in Inventories of -$866.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInInventories · last filed 2026-07-23
- NovoCure Limited increase (decrease) in inventories for the quarter ending 2026-06-30 was -$866.00K, a 237.68% decline year-over-year.
- NovoCure Limited increase (decrease) in inventories for the quarter ending 2026-03-31 was $2.78M, a 29.51% decline year-over-year.
- NovoCure Limited increase (decrease) in inventories for the quarter ending 2025-12-31 was $1.98M.
- NovoCure Limited increase (decrease) in inventories for the quarter ending 2025-09-30 was -$886.00K.
- NovoCure Limited increase (decrease) in inventories for fiscal 2024 was -$2.57M, a 128.79% decline from fiscal 2023.
- NovoCure Limited increase (decrease) in inventories for fiscal 2023 was $8.92M, a 105.41% increase from fiscal 2022.
- NovoCure Limited increase (decrease) in inventories for fiscal 2022 was $4.34M.
- NovoCure Limited increase (decrease) in inventories for fiscal 2021 was -$2.48M, a 184.60% decline from fiscal 2020.
| Period end | Increase (Decrease) in Inventories 3 month | Increase (Decrease) in Inventories 6 month | Increase (Decrease) in Inventories 9 month | Increase (Decrease) in Inventories 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$866.00K 10-Q · filed 2026-07-23 | $1.91M 10-Q · filed 2026-07-23 | $3.90M derived: sum of 3 quarters · filed 2026-07-23 | $3.01M derived: sum of 4 quarters · filed 2026-07-23 |
| 2026-03-31 | $2.78M 10-Q · filed 2026-04-30 | $4.76M derived: sum of 2 quarters · filed 2026-07-23 | $3.88M derived: sum of 3 quarters · filed 2026-07-23 | $4.50M derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-12-31 | $1.98M derived: 10-Q 12 month − 10-Q 9 month · filed 2026-07-23 | $1.10M derived: sum of 2 quarters · filed 2026-07-23 | $1.73M derived: sum of 3 quarters · filed 2026-07-23 | $5.67M 10-Q · filed 2026-07-23 |
| 2025-09-30 | -$886.00K 10-Q · filed 2025-10-30 | -$257.00K derived: sum of 2 quarters · filed 2026-07-23 | $3.68M 10-Q · filed 2025-10-30 | $249.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-06-30 | $629.00K 10-Q · filed 2026-07-23 | $4.57M 10-Q · filed 2026-07-23 | $1.14M derived: sum of 3 quarters · filed 2026-07-23 | -$760.00K derived: sum of 4 quarters · filed 2026-07-23 |
| 2025-03-31 | $3.94M 10-Q · filed 2026-04-30 | $506.00K derived: sum of 2 quarters · filed 2026-04-30 | -$1.39M derived: sum of 3 quarters · filed 2026-04-30 | -$3.28M derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | -$3.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$5.33M derived: sum of 2 quarters · filed 2026-02-26 | -$7.22M derived: sum of 3 quarters · filed 2026-02-26 | -$2.57M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.90M 10-Q · filed 2025-10-30 | -$3.78M derived: sum of 2 quarters · filed 2025-10-30 | $867.00K 10-Q · filed 2025-10-30 | $1.54M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | -$1.89M 10-Q · filed 2025-07-24 | $2.76M 10-Q · filed 2025-07-24 | $3.43M derived: sum of 3 quarters · filed 2026-02-26 | $7.51M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $4.65M 10-Q · filed 2025-04-24 | $5.32M derived: sum of 2 quarters · filed 2026-02-26 | $9.40M derived: sum of 3 quarters · filed 2026-02-26 | $10.85M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $669.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $4.75M derived: sum of 2 quarters · filed 2026-02-26 | $6.20M derived: sum of 3 quarters · filed 2026-02-26 | $8.92M 10-K · filed 2026-02-26 |
| 2023-09-30 | $4.08M 10-Q · filed 2024-10-30 | $5.53M derived: sum of 2 quarters · filed 2024-10-30 | $8.25M 10-Q · filed 2024-10-30 | $10.53M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.45M 10-Q · filed 2024-07-25 | $4.17M 10-Q · filed 2024-07-25 | $6.45M derived: sum of 3 quarters · filed 2025-02-27 | $3.50M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $2.72M 10-Q · filed 2024-05-02 | $5.00M derived: sum of 2 quarters · filed 2025-02-27 | $2.05M derived: sum of 3 quarters · filed 2025-02-27 | $2.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.28M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$671.00K derived: sum of 2 quarters · filed 2025-02-27 | -$462.00K derived: sum of 3 quarters · filed 2025-02-27 | $4.34M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$2.95M 10-Q · filed 2023-10-26 | -$2.74M derived: sum of 2 quarters · filed 2023-10-26 | $2.06M 10-Q · filed 2023-10-26 | $3.76M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $209.00K 10-Q · filed 2023-07-27 | $5.01M 10-Q · filed 2023-07-27 | $6.71M derived: sum of 3 quarters · filed 2024-02-22 | $2.90M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $4.80M 10-Q · filed 2023-05-04 | $6.51M derived: sum of 2 quarters · filed 2024-02-22 | $2.69M derived: sum of 3 quarters · filed 2024-02-22 | $1.02M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.12M derived: sum of 2 quarters · filed 2024-02-22 | -$3.78M derived: sum of 3 quarters · filed 2024-02-22 | -$2.48M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$3.82M 10-Q · filed 2022-10-27 | -$5.48M derived: sum of 2 quarters · filed 2022-10-27 | -$4.18M 10-Q · filed 2022-10-27 | -$3.70M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | -$1.66M 10-Q · filed 2022-07-28 | -$367.00K 10-Q · filed 2022-07-28 | $122.00K derived: sum of 3 quarters · filed 2023-02-23 | $177.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $1.30M 10-Q · filed 2022-04-28 | $1.78M derived: sum of 2 quarters · filed 2023-02-23 | $1.84M derived: sum of 3 quarters · filed 2023-02-23 | $5.38M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $489.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $544.00K derived: sum of 2 quarters · filed 2023-02-23 | $4.08M derived: sum of 3 quarters · filed 2023-02-23 | $2.94M 10-K · filed 2023-02-23 |
| 2020-09-30 | $55.00K 10-Q · filed 2021-10-28 | $3.59M derived: sum of 2 quarters · filed 2021-10-28 | $2.45M 10-Q · filed 2021-10-28 | $1.77M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $3.54M 10-Q · filed 2021-07-29 | $2.39M 10-Q · filed 2021-07-29 | $1.72M derived: sum of 3 quarters · filed 2022-02-24 | $652.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$1.15M 10-Q · filed 2021-04-29 | -$1.82M derived: sum of 2 quarters · filed 2022-02-24 | -$2.89M derived: sum of 3 quarters · filed 2022-02-24 | -$1.57M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$673.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$1.74M derived: sum of 2 quarters · filed 2022-02-24 | -$424.00K derived: sum of 3 quarters · filed 2022-02-24 | $1.16M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$1.07M 10-Q · filed 2020-10-29 | $249.00K derived: sum of 2 quarters · filed 2020-10-29 | $1.83M 10-Q · filed 2020-10-29 | $2.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $1.32M 10-Q/A · filed 2020-10-02 | $2.90M 10-Q/A · filed 2020-10-02 | $3.81M derived: sum of 3 quarters · filed 2021-02-25 | $5.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $1.58M 10-Q/A · filed 2020-10-02 | $2.50M derived: sum of 2 quarters · filed 2021-02-25 | $4.23M derived: sum of 3 quarters · filed 2021-02-25 | $3.75M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $914.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $2.65M derived: sum of 2 quarters · filed 2021-02-25 | $2.17M derived: sum of 3 quarters · filed 2021-02-25 | $529.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $1.74M 10-Q · filed 2019-10-31 | $1.25M derived: sum of 2 quarters · filed 2019-10-31 | -$385.00K 10-Q · filed 2019-10-31 | -$3.00M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | -$482.00K 10-Q · filed 2019-07-25 | -$2.12M 10-Q · filed 2019-07-25 | -$4.74M derived: sum of 3 quarters · filed 2020-02-27 | -$5.24M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | -$1.64M 10-Q · filed 2019-05-02 | -$4.25M derived: sum of 2 quarters · filed 2020-02-27 | -$4.76M derived: sum of 3 quarters · filed 2020-02-27 | -$5.56M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | -$2.62M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$3.12M derived: sum of 2 quarters · filed 2020-02-27 | -$3.92M derived: sum of 3 quarters · filed 2020-02-27 | -$3.52M 10-K · filed 2020-02-27 |
| 2017-09-30 | -$504.00K 10-Q · filed 2018-10-25 | -$1.31M derived: sum of 2 quarters · filed 2018-10-25 | -$907.00K 10-Q · filed 2018-10-25 | $670.00K derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-06-30 | -$803.00K 10-Q · filed 2018-07-26 | -$403.00K 10-Q · filed 2018-07-26 | $1.17M derived: sum of 3 quarters · filed 2019-02-28 | $3.93M derived: sum of 4 quarters · filed 2019-02-28 |
| 2017-03-31 | $400.00K 10-Q · filed 2018-04-26 | $1.98M derived: sum of 2 quarters · filed 2019-02-28 | $4.73M derived: sum of 3 quarters · filed 2019-02-28 | $9.50M derived: sum of 4 quarters · filed 2019-02-28 |
| 2016-12-31 | $1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | $4.33M derived: sum of 2 quarters · filed 2019-02-28 | $9.10M derived: sum of 3 quarters · filed 2019-02-28 | $11.96M 10-K · filed 2019-02-28 |
| 2016-09-30 | $2.76M 10-Q · filed 2017-10-26 | $7.53M derived: sum of 2 quarters · filed 2017-10-26 | $10.38M 10-Q · filed 2017-10-26 | $12.82M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $4.77M 10-Q · filed 2017-07-27 | $7.62M 10-Q · filed 2017-07-27 | $10.07M derived: sum of 3 quarters · filed 2018-02-22 | $12.62M derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $2.85M 10-Q · filed 2017-04-27 | $5.30M derived: sum of 2 quarters · filed 2018-02-22 | $7.85M derived: sum of 3 quarters · filed 2018-02-22 | $9.27M derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | $2.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | $5.00M derived: sum of 2 quarters · filed 2018-02-22 | $6.42M derived: sum of 3 quarters · filed 2018-02-22 | $10.15M 10-K · filed 2018-02-22 |
| 2015-09-30 | $2.56M 10-Q · filed 2016-11-02 | $3.97M derived: sum of 2 quarters · filed 2016-11-02 | $7.70M 10-Q · filed 2016-11-02 | $8.45M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $1.42M 10-Q · filed 2016-07-28 | $5.15M 10-Q · filed 2016-07-28 | $5.90M derived: sum of 3 quarters · filed 2017-02-23 | |
| 2015-03-31 | $3.73M 10-Q · filed 2016-05-10 | $4.48M derived: sum of 2 quarters · filed 2017-02-23 | ||
| 2014-12-31 | $750.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $1.55M 10-K · filed 2017-02-23 | ||
| 2014-09-30 | $804.00K 10-Q · filed 2015-10-27 | |||
| 2013-12-31 | -$1.48M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |